XML 61 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Note 17 - Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2025
Notes Tables  
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
  

Fiscal years ended March 31,

 
  

2025

  

2024

 

Stock options

 $8  $40 

Restricted stock and stock awards

  7,732   4,563 

Employee stock purchase plan

  54   49 

Total stock-based compensation expense

 $7,794  $4,652 
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
  

Fiscal years ended March 31,

 
  

2025

  

2024

 

Cost of revenues

 $536  $293 

Research and development

  1,132   627 

Selling, general and administrative

  6,126   3,732 

Total

 $7,794  $4,652 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
  

Options /

Shares

  

Weighted-Average Exercise Price

  

Weighted-Average Remaining Contractual Term

  

Aggregate Intrinsic Value (thousands)

 

Outstanding at March 31, 2024

  36,206  $6.94         

Granted

              

Exercised

              

Canceled/forfeited

              

Outstanding at March 31, 2025

  36,206  $6.94   5.2  $406 

Exercisable at March 31, 2025

  36,206  $6.94   5.2  $406 

Fully vested and expected to vest at March 31, 2025

  36,206  $6.94   5.2  $406 
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
  

Shares

  

Weighted Average Grant Date Fair Value

  

Intrinsic Aggregate Value (thousands)

 

Outstanding at March 31, 2024

  1,425,654  $6.74     

Granted

  891,700   21.99     

Vested

  (524,201)  8.50     

Forfeited

  (3,000)  5.94     

Outstanding at March 31, 2025

  1,790,153  $13.82  $32,473